Table 1.
Baseline characteristics
| Variable | Value | |
|---|---|---|
| Patients, n | 233 | |
| Male sex, n (%) | 182 | (78.11) |
| Age, M (range) | 54 | (25–73) |
| CTP class A/B/C, n (%) | 227/6/0 | (97.42/2.58/0) |
| Tumor maximum size, cm, M (range) | 4.1 | (2.1–9.7) |
| HBV DNA, log copies/ml | 3.9 | (3.0–5.1) |
| HBeAg postive, n (%) | 164 | (70.39) |
| Cirrhosis, n (%) | 96 | (41.20) |
| AFP, ng/mL, M (range) | 103.7 | (7.8–1210) |
| TBIL, mmol/L, M (range) | 5.87 | (2.60–64.70) |
| ALT, IU/L, M (range) | 26 | (11–57) |
| AST, IU/L, M (range) | 27 | (19–78) |
| ALP, IU/L, M (range) | 51 | (45–187) |
| ALB, g/L, M (range) | 3.9 | (2.3–5.7) |
| PLT, 10^9/L, M (range) | 163.5 | (79–241) |
| PT, s, M (range) | 12.1 | (11.3–13.6) |
| INR, M (range) | 0.99 | (0.77–1.24) |
AFP = α-fetoprotein, ALB = albumin, ALP = alkaline phosphatase, ALT = alanine aminotransferase, AST = aspartate aminotransferase, CTP=Child–Trucott–Pugh score, HBV = hepatitis B virus, INR = international normalized ratio, PLT = platelet, PT = prothrombin time, TBIL = total bilirubin